Skip to main content
. 2005 May;73(5):2644–2654. doi: 10.1128/IAI.73.5.2644-2654.2005

TABLE 4.

Intranasal LVS vaccination protected mice against s.c. NMFTA1 challengea

Vaccination status Challenge dose (CFU) Survival (no. of survivors/no. tested)
None 2 × 102 0/9
None 2 × 103 0/4
LVS 2 × 102 8/9
LVS 2 × 103 7/9
a

BALB/c mice were vaccinated i.n. with 200 CFU of LVS and 3 weeks later were challenged s.c. with 2 × 102 or 2 × 103 CFU of NMFTA1. The results show survival ratios on day 30 postchallenge, and all deaths occurred 5 to 6 days after challenge.